Literature DB >> 33428642

Comparison of the accuracy of diagnoses of oral potentially malignant disorders with dysplasia by a general dental clinician and a specialist using the Taiwanese Nationwide Oral Mucosal Screening Program.

Tien-En Chiang1,2, Yu-Chun Lin3, Chi-Tsung Wu1,2, Cheng-Yu Yang2, Sheng-Tang Wu4,5, Yuan-Wu Chen1,2.   

Abstract

Screening for oral potentially malignant disorders (OPMDs) with dysplasia in high-risk groups is suggested in countries with a high prevalence of the disorders. This study aimed to compare the accuracy of diagnoses of OPMDs with dysplasia made by a primary examiner (general dental clinician) and a specialist (oral and maxillofacial surgeon) using the current Taiwanese Nationwide Oral Mucosal Screening Program (TNOMSP). A total of 134 high-risk participants were enrolled for oral mucosal screening via the TNOMSP. A primary examiner and a specialist examined each participant. Mucosal biopsies were obtained and subjected to histopathological analysis. The OPMD most frequently diagnosed by the primary examiner was thin homogeneous leukoplakia (48/134; 35.8%), and in 39/134 participants (29.1%) the diagnosis was uncertain, but abnormalities were suggested. The OPMDs most frequently diagnosed by the specialist were erythroleukoplakia (23/134; 17.2%) and thin homogeneous leukoplakia (21/134; 15.7%), and 51/134 participants (38.1%) were diagnosed with other diseases. Via histopathology, 70/134 participants (52.3%) were diagnosed with dysplasia, and 58/134 (43.3%) were diagnosed with benign conditions. The specialist's diagnoses exhibited a higher specificity, positive predictive value, and accuracy than the primary examiners. A specialist using the current TNOMSP for high-risk participants diagnosed OPMDs with dysplasia more accurately than a primary examiner. Early diagnosis of high-risk OPMDs is crucial in countries with a high prevalence of the disorders. Proficient examination via the current TNOMSP by trained clinician is effective for the management of OPMDs with dysplasia.

Entities:  

Year:  2021        PMID: 33428642      PMCID: PMC7799778          DOI: 10.1371/journal.pone.0244740

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  38 in total

1.  Malignant transformation of oral submucous fibrosis in Taiwan: A nationwide population-based retrospective cohort study.

Authors:  Po-Yu Yang; Yi-Tzu Chen; Yu-Hsun Wang; Ni-Yu Su; Hui-Chieh Yu; Yu-Chao Chang
Journal:  J Oral Pathol Med       Date:  2017-04-06       Impact factor: 4.253

2.  Mucosal disorders with oral epithelial dysplasia risk--development of a simple screening tool for general health care setting.

Authors:  Valsa Thomas; S Rema Devi; Visalakshi Jeyaseelan; L Jeyseelan
Journal:  Oral Oncol       Date:  2012-03-13       Impact factor: 5.337

3.  Early findings from a community-based, cluster-randomized, controlled oral cancer screening trial in Kerala, India. The Trivandrum Oral Cancer Screening Study Group.

Authors:  R Sankaranarayanan; B Mathew; B J Jacob; G Thomas; T Somanathan; P Pisani; M Pandey; K Ramadas; K Najeeb; E Abraham
Journal:  Cancer       Date:  2000-02-01       Impact factor: 6.860

Review 4.  Management update of potentially premalignant oral epithelial lesions.

Authors:  Michael Awadallah; Matthew Idle; Ketan Patel; Deepak Kademani
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2018-03-23

5.  Intercountry prevalences and practices of betel-quid use in south, southeast and eastern Asia regions and associated oral preneoplastic disorders: an international collaborative study by Asian betel-quid consortium of south and east Asia.

Authors:  Chien-Hung Lee; Albert Min-Shan Ko; Saman Warnakulasuriya; Bang-Liang Yin; Rosnah Binti Zain; Salah Osman Ibrahim; Zhi-Wen Liu; Wen-Hui Li; Shan-Shan Zhang; Budi Utomo; Palandage Sunethra Rajapakse; Supun Amila Warusavithana; Ishak Abdul Razak; Norlida Abdullah; Prashanta Shrestha; Aij-Lie Kwan; Tien-Yu Shieh; Mu-Kuan Chen; Ying-Chin Ko
Journal:  Int J Cancer       Date:  2011-03-08       Impact factor: 7.396

Review 6.  Molecular markers in oral epithelial dysplasia: review.

Authors:  Gayani Pitiyage; W M Tilakaratne; Mahvash Tavassoli; Saman Warnakulasuriya
Journal:  J Oral Pathol Med       Date:  2009-11       Impact factor: 4.253

7.  Outcomes of oral squamous cell carcinoma in Taiwan after surgical therapy: factors affecting survival.

Authors:  Wen-Liang Lo; Shou-Yen Kao; Lin-Yang Chi; Yong-Kie Wong; Richard Che-Shoa Chang
Journal:  J Oral Maxillofac Surg       Date:  2003-07       Impact factor: 1.895

8.  Malignant development in patients with oral potentially malignant disorders detected through nationwide screening: Outcomes of 5-year follow-up at a single hospital.

Authors:  Wei-Fan Chiang; Shyun-Yeu Liu; Jen-Fen Lin; Sheng-Fu Chiu; Shin-Bin Gou; Chang-Ta Chiou; Chi-Hua Chang
Journal:  Head Neck       Date:  2019-10-07       Impact factor: 3.147

Review 9.  Detection and screening of oral cancer and pre-cancerous lesions.

Authors:  Shou-Yen Kao; Yu-Wei Chu; Ya-Wei Chen; Kuo-Wei Chang; Tsung-Yun Liu
Journal:  J Chin Med Assoc       Date:  2009-05       Impact factor: 2.743

Review 10.  Epithelial dysplasia in oral cavity.

Authors:  Samaneh Shirani; Neda Kargahi; Sayed Mohammad Razavi; Solmaz Homayoni
Journal:  Iran J Med Sci       Date:  2014-09
View more
  2 in total

1.  Dentists' Perception of Oral Potentially Malignant Disorders.

Authors:  Bassel Tarakji
Journal:  Int Dent J       Date:  2022-02-26       Impact factor: 2.607

2.  Improving the Diagnostic Performance by Adding Methylation Marker to Conventional Visual Examination in Identifying Oral Cancer.

Authors:  Cheng-Chieh Yang; Yee-Fun Su; Han-Chieh Cheng; Yi-Chen Juan; Yu-Wei Chiu; Cheng-Hsien Wu; Pei-Yin Chen; Yu-Hsien Lee; Yen-Lin Chen; Yi-Tzu Chen; Chih-Yu Peng; Ming-Yi Lu; Chuan-Hang Yu; Yu-Feng Huang; Shou-Yen Kao; Chyng-Wen Fwu; Chung-Ji Liu
Journal:  Diagnostics (Basel)       Date:  2022-06-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.